Italy's connected healthcare market is projected to grow from $1.59 Bn in 2022 to $11.41 Bn by 2030, registering a CAGR of 27.9% during the forecast period of 2022-30. The main factors driving the growth would be the rising geriatric population, chronic disease prevalence, technological advancements and government support. The market is segmented by type, function and by application. Some of the major players include Reply, D0Eye, Plusimple, Philips Healthcare, IBM and Siemens Healthineers.
Italy Connected Healthcare Market Executive Summary
Italy's connected healthcare market is projected to grow from $1.59 Bn in 2022 to $11.41 Bn by 2030, registering a CAGR of 27.9% during the forecast period of 2022-30. In 2019, Italy spent $2,906 per person on healthcare or 8.67% of its GDP. In 2019 health spending lagged substantially behind the EU average in both per capita spending and as a percentage of GDP. In 2019, the government paid for about 74% of health expenses, which is less than the average for the EU of 80%.
The market for connected healthcare refers to the use of digital technologies and connected devices to improve patient care and healthcare delivery. Pharmaceutical firms and healthcare organisations have also made progress with these technologies. During the pandemic year in Italy, 47% of specialists and 39% of family practitioners conducted teleconsultations. For instance, the ASST Grande Ospedale Metropolitano Niguarda started a televisit scheme to give patients who were bedridden follow-up exams. To lessen physical touch, some Italian hospitals also purchased inpatient remote monitoring systems or employed apps to monitor patients.
Market Growth Drivers
The Italy-connected healthcare market is expected to be driven by factors such as:
Market Restraints
The following factors are expected to limit the growth of the connected healthcare market in Italy:
Key Players
April 2023: e-Telemed 2023, the Fifteenth International Conference on e-health, social medicine and telemedicine is scheduled to be held in Venice, Italy from 24th April -28th April.
With the development of connected healthcare technology during the past few years, the Italian healthcare market has been expanding quickly. The Italian Medicines Agency (AIFA), which is tasked with assessing and approving medical devices and digital health solutions, oversees the regulatory framework for linked healthcare in Italy. These solutions' quality, safety, and efficacy are evaluated by the agency, which also decides whether they qualify for marketing and funding.
In order to encourage the adoption of digital health solutions, such as telemedicine and e-prescriptions, the Italian government has put in place a number of measures. A law allowing for the financing of telemedicine services, such as remote consultations and chronic disease monitoring, was introduced by the government in 2017. The law also permits the reimbursement of electronic prescriptions, allowing patients to get their medications electronically. Also, the government has put in place a national electronic health record system (SEPS), which makes it possible for healthcare professionals to collect and share health data. The system enhances patient continuity of care and gives medical staff real-time access to patient data.
Italy has a comprehensive healthcare system that offers all inhabitants access to care. To encourage the implementation of digital health solutions, such as telemedicine and e-prescriptions, the government has put in place a number of policies. The Italian healthcare system also has a well-established reimbursement strategy that includes connected healthcare technologies and covers a wide spectrum of healthcare services.
The Italian Medicines Agency (AIFA) is in charge of determining how connected healthcare solutions are reimbursed in the country. The organisation determines whether medical equipment and digital health solutions are eligible for reimbursement by assessing their quality, safety, and efficacy. The Italian government has created tax incentives and subsidies to encourage innovation and investment in the healthcare sector, in addition to the reimbursement policy for telemedicine and connected healthcare solutions.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
Based on the Type the market is segmented into mHealth services, mHealth Devices, and E- Prescription
By FunctionType (Revenue, USD Billion):
By Application Type (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The Italy-connected healthcare market is projected to grow from $1.59 Bn in 2022 to $11.41 Bn by 2030, registering a CAGR of 27.9% during the forecast period of 2022 - 2030.
The Italy-connected healthcare market is segmented by type (m-health services, m-health devices and e-prescription), by function (remote patient monitoring, clinical monitoring, telemedicine and others), and by application type (diagnosis and treatment, monitoring application, wellness and prevention, healthcare management and others).
Some of the major players in Italy's connected healthcare market are Reply, D-Eye, Plusimple, Philips Healthcare, IBM and Siemens Healthineers.